parthenolide has been researched along with Nephritis, Interstitial in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benito-Martín, A; Blanco, J; Carrasco, S; Egido, J; Izquierdo, MC; Mezzano, S; Ortiz, A; Ruiz-Ortega, M; Sanchez-Niño, MD; Sanz, AB | 1 |
1 other study(ies) available for parthenolide and Nephritis, Interstitial
| Article | Year |
|---|---|
TWEAK (tumor necrosis factor-like weak inducer of apoptosis) activates CXCL16 expression during renal tubulointerstitial inflammation.
Topics: Adult; Animals; Antibodies, Neutralizing; Biopsy; Cell Line; Chemokine CXCL16; Chemokine CXCL6; Chemokines, CXC; Chemotaxis; Cytokine TWEAK; Disease Models, Animal; Female; Folic Acid; Gene Expression Profiling; Humans; Kidney Tubules; Male; Mice; Mice, Inbred C57BL; Middle Aged; Nephritis, Interstitial; NF-kappa B; Receptors, Scavenger; Receptors, Tumor Necrosis Factor; Recombinant Proteins; RNA, Messenger; Sesquiterpenes; T-Lymphocytes; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factors; TWEAK Receptor; Up-Regulation | 2012 |